Error message
Notice: Undefined index: content in _drupal_default_html_head() (line 345 of /var/www/vhosts/rovi.es/httpdocs/includes/common.inc).
|
Date |
Title |
Description |
PDF |
|
06 Nov 2025 |
On P&L |
The Company releases the press release related to the first nine months of 2025 financial results
|
Download |
|
06 Nov 2025 |
On P&L |
The Company releases the first nine months of 2025 financial results presentation
|
Download |
|
21 Oct 2025 |
On business and financial situation |
The Company releases the press release in relation to the announcement of the collaboration with Roche for the manufacture of a new medicine in development
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
ROVI announces the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
|
29 Sep 2025 |
On corporate transactions: mergers, acquisitions and others |
The Company releases the presentation related to the acquisition of an injectable drug product manufacturing site in Phoenix, Arizona (USA)
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
22 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 15 March and 21 March 2024
|
Download |
|
15 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 8 March and 14 March 2024
|
Download |
|
12 Mar 2024 |
On business and financial situation |
ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
|
Download |
|
08 Mar 2024 |
Share buy-back , stabilisation and treasury stock programmes |
Share Buyback Program: transactions conducted between 1 March and 7 March 2024
|
Download |
|
07 Mar 2024 |
On corporate transactions |
ROVI notes the recent press speculation and informs about the assessment of potential strategic alternatives
|
Download |
Pages
|
Date |
Title |
Description |
PDF |
|
05 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: modification of transactions conducted from 11 July to 30 September 2017.
|
Download |
|
03 Oct 2017 |
Contratos de liquidez y contrapartida |
Liquidity contract: transactions conducted from 11 July to 30 September 2017
|
Download |
|
07 Sep 2017 |
Otros sobre negocio y situación financiera |
The Company informs that commences the enoxaparin biosimilar marketing in Germany
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
|
26 Jul 2017 |
Información sobre resultados |
ROVI releases the presentation related to the 2017 first half results
|
Download |
Pages
